FIELD: biotechnology.
SUBSTANCE: group of inventions is described, comprising a pharmaceutical composition for polypeptide expression in a mammalian cell and application of a composition for preparation of a medicament to increase the level of the polypeptide of interest in a mammal. The specified polynucleotide contains: (a) an open reading frame encoding the specified polypeptide consisting of nucleosides, including 1-methyl pseudouridine, cytidine or 5-methylcytidine, adenosine, and guanosine, (b) 5'-UTR, (c) 3'-UTR, and (d) 5'-cap structure.
EFFECT: invention expands the arsenal of means for polynucleotides expressing.
6 cl, 10 dwg, 50 tbl, 90 ex
Title | Year | Author | Number |
---|---|---|---|
MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND USE THEREOF | 2012 |
|
RU2707251C2 |
MODIFIED NUCLEOSIDE, NUCLEOTIDE AND NUCLEIC ACID COMPOSITIONS | 2012 |
|
RU2649364C2 |
5'-CAP-TRINUCLEOTIDE COMPOUNDS OR 5'-CAP COMPOUNDS WITH LARGE NUMBER OF NUCLEOTIDES AND THEIR USE FOR RNA STABILIZATION, PROTEIN EXPRESSION AND IN THERAPY | 2019 |
|
RU2811940C2 |
ANTICANCER RNA VACCINES | 2017 |
|
RU2768829C2 |
VACCINES BASED ON NUCLEIC ACIDS | 2015 |
|
RU2746406C2 |
POLYNUCLEOTIDES CODING INTERLEUKIN-12 (IL12), AND APPLICATIONS THEREOF | 2017 |
|
RU2769316C2 |
mRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION | 2020 |
|
RU2810003C2 |
METHODS AND MEANS OF INCREASING PRODUCTIVITY OF RNA | 2015 |
|
RU2738753C2 |
METHOD FOR INCREASING THE EXPRESSION OF ENCODED RNA PROTEINS | 2014 |
|
RU2733424C2 |
COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
Authors
Dates
2018-04-02—Published
2012-10-03—Filed